Atlas Trials

Immunogenicity Study of Insulin Glargine Ezelin vs Lantus in Type 2 Diabetes Mellitus Patients

Clinical trial NCT03352674 · COMPLETED

Trial details

NCT number
NCT03352674
Sponsor
Indonesia University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2016-09-01
Primary completion
2018-12-01
Enrollment
133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.